Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
The industry rank for Riverstone Holdings's 9-Day RSI or its related term are showing as below:
SGX:AP4's 9-Day RSI is ranked worse than 79.05% of 864
companies
in the Medical Devices & Instruments industry
Industry Median: 47.035
vs SGX:AP4: 57.66
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Riverstone Holdings 9-Day RSI Related Terms
SGX:AP4 vs ISRG, BDX, MDLN: 9-Day RSI Comparison
For the Medical Instruments & Supplies subindustry, Riverstone Holdings's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Riverstone Holdings 9-Day RSI vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Riverstone Holdings's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where Riverstone Holdings's 9-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Riverstone Holdings (SGX:AP4) has a 9-Day RSI of 57.66 as of Jul. 28, 2026. According to the industry distribution chart, Riverstone Holdings ranks #683 out of 864 companies in the Medical Devices & Instruments industry, placing it in the top 79.1%.
Is Riverstone Holdings' 9-Day RSI too high?
Riverstone Holdings' current 9-Day RSI is 57.66. The Medical Devices & Instruments industry median 9-Day RSI is 47.04. Riverstone Holdings' value of 57.66 is 22.6% above this industry median. Based on the distribution chart, Riverstone Holdings ranks #683 out of 864 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Riverstone Holdings has a GF Score™ of 62/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Riverstone Holdings' 9-Day RSI compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Riverstone Holdings ranks #683 out of 864 companies for 9-Day RSI. This places Riverstone Holdings in the lower half of its industry. The industry median 9-Day RSI is 47.04. Riverstone Holdings' value of 57.66 is 22.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Medical Devices & Instruments company?
The median 9-Day RSI among Medical Devices & Instruments companies is 47.04, based on 864 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Riverstone Holdings's current 9-Day RSI of 57.66 is 22.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median 9-Day RSI is 47.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Riverstone Holdings's current 9-Day RSI is 57.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Riverstone Holdings stock overvalued right now?
Based on GuruFocus' analysis, Riverstone Holdings (SGX:AP4) is currently considered Fairly Valued. The stock's GF Value™ is S$0.87, compared to a current price of S$0.87 — trading 0.6% below its estimated fair value. The current 9-Day RSI is 57.66 and 22.6% above the Medical Devices & Instruments industry median of 47.04. Riverstone Holdings' overall GF Score™ is 62/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Riverstone Holdings (SGX:AP4), the current 9-Day RSI is 57.66 as of Jul. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Riverstone Holdings (SGX:AP4) Overvalued in 2026?
Based on GuruFocus' analysis, Riverstone Holdings stock appears to be undervalued.
The current stock price of S$0.87 is trading 0.6% below its estimated GF Value™ of S$0.87.
GuruFocus considers Riverstone Holdings to be Fairly Valued.
Key valuation signals for SGX:AP4:
9-Day RSI: 57.66
GF Value™: S$0.87 vs. price of S$0.87 (0.6% below fair value)
Industry Position: 22.6% above the Medical Devices & Instruments median (#683 of 864)
No single metric tells the full story. See the SGX:AP4 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Riverstone Holdings Ltd is an investment holding company. Along with its subsidiaries, the company is engaged in the manufacture and sales of gloves and non-glove consumables such as finger cots, static shielding bags, face masks, wipers, and packaging materials. The group's products are widely qualified and used in the Hard Disk Drive, and semiconductor industries. It operates in three segments based on its geography: Malaysia, Thailand, China, Singapore, and Others, of which the majority of its revenue comes from Malaysia.
62GF Score
Get the complete analysis for SGX:AP4
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:AP4 has been successfully added to your 
